▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3394 by analyst upside · 2026-06-27
CAH
Cardinal Health, Inc.
Healthcare · Market Cap $56B · P/E 35.8x
ANALYST PRICE TARGET
+3.1%
implied upside to consensus target
Current Price $237.92
Consensus Target $245.27
Bull Target $275.0
Bear Target $215.0
Analysts Covering 15
ANALYST CONSENSUS - BUY
Strong Buy
2
Buy
10
Hold
4
Sell
0
52-Week Low $137.75
52-Week High $240.39
YTD Return +15.9%
FUNDAMENTALS
Market Cap $56B
P/E Ratio (TTM) 35.8x
Forward P/E 19.8x
EPS (TTM) $6.64
PEG Ratio 1.44
Dividend Yield 0.86%
Revenue (TTM) $250.7B
Profit Margin 0.6%
52-WEEK RANGE
52-Week Low $137.75
52-Week High $240.39
Current Price $237.92
Bear Target $215.0
Bull Target $275.0
● Now $237.92 ● Target $245.27
TRADING DATA
Avg Volume 2.1M
YTD Return +15.9%
Analyst Count 15
Consensus Buy
Upside to Target +3.1%
Last Updated 2026-06-27

ANALYST SUMMARY

Cardinal Health, Inc. (CAH) is currently trading at $237.92 with a Wall Street consensus price target of $245.27, implying potential upside of 3.1% over the next 12 months. 15 analysts currently cover CAH, with a consensus rating of Buy - 75% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $275.0, while the most cautious has a target of $215.0.

CAH operates in the Healthcare sector with a market capitalisation of $56B. The stock is up 15.9% year-to-date and is currently trading near the upper end of its 52-week range of $137.75 – $240.39.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

EW +6.8%
Edwards Lifesciences Corporation
$52B · P/E 48.5x · Buy
ARGX +17.4%
argenx SE
$55B · P/E 39.5x · Buy
COR +22.7%
Cencora, Inc.
$56B · P/E 21.9x · Buy
BDX +14.0%
Becton, Dickinson and Company
$43B · P/E 26.4x · Hold
HUM -20.7%
Humana Inc.
$46B · P/E 40.2x · Hold

RECENT ANALYST CALLS

Upgrade/downgrade history for CAH, with each firm's 90-day track record across all stocks we track. See full firm rankings →

JP Morgan — Reiterated
Neutral → Neutral 2026-05-04 43% win rate (7 calls)
Citigroup — Reiterated
Buy → Buy 2026-05-01 Building track record
TD Cowen — Reiterated
Buy → Buy 2026-05-01 Building track record
Wells Fargo — Reiterated
Overweight → Overweight 2026-05-01 Building track record
William Blair ● Initiated
Outperform 2026-04-28 44% win rate (9 calls)
Evercore ISI Group — Reiterated
Outperform → Outperform 2026-04-08 Building track record
Barclays — Reiterated
Overweight → Overweight 2026-02-24 Building track record
JP Morgan — Reiterated
Neutral → Neutral 2026-02-10 43% win rate (7 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
60
out of 100
Coverage depth
21/30
Consensus clarity
25/30
Vote unanimity
12/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →